Reduced breast cancer risk with increasing serum folate in a case–control study of the C677T genotype of the methylenetetrahydrofolate reductase gene
- 31 May 2004
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (8) , 1250-1254
- https://doi.org/10.1016/j.ejca.2004.01.026
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Plasma Folate, Vitamin B6, Vitamin B12, Homocysteine, and Risk of Breast CancerJNCI Journal of the National Cancer Institute, 2003
- Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectumAmerican Journal of Medical Genetics, 2001
- Biological and clinical implications of the MTHFR C677T polymorphismTrends in Pharmacological Sciences, 2001
- Dietary Folate Consumption and Breast Cancer RiskJNCI Journal of the National Cancer Institute, 2000
- A Prospective Study of Folate Intake and the Risk of Breast CancerJAMA, 1999
- Folate and carcinogenesis: evidence, mechanisms, and implicationsPublished by Elsevier ,1999
- Intake of fruits, vegetables, folic acid and related nutrients and risk of breast cancer in postmenopausal womenPublic Health Nutrition, 1998
- Case-control study of phyto-oestrogens and breast cancerThe Lancet, 1997
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Urinary Ammonia Plus Urinary Urea Nitrogen as an Estimate of Total Urinary Nitrogen in Patients Receiving Parenteral Nutrition SupportJournal of Parenteral and Enteral Nutrition, 1993